Effect of thoracic paravertebral nerve block on the quality of recovery after throracoscopic lobectomy

Study on analgesic effect and rapid rehabilitation of dexmedetomine and thoracic paravertebral block after thoracic surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054207

Enrollment

Unknown

Registered

2021-12-11

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Experimental group:TPVB

Control group:No

Eligibility

Sex/Gender

All

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing throracoscopic lobectomy under general anesthesia; 2. Aged 25-65 years; 3. BMI 19~28 kg/m^2; 4. ASA grade I~II.

Exclusion criteria

Exclusion criteria: 1. Previous history of neurological and psychiatric diseases; 2. Preoperative anticoagulant or antiplatelet therapy, abnormal liver and kidney function, coagulation dysfunction; 3. Local anesthetic allergy; 4. History of acute and chronic pain; 5. Chest and spinal deformity; 6. Puncture site damage and infection, etc.

Design outcomes

Primary

Measure	Time frame
QOR-40 (40-item questionnaire as a measure of quality of recovery);Visual analogue scale (VAS);	—

Secondary

Measure	Time frame
Cumulative consumption of opioids;Time to wake up and stay in the recovery room;Postoperative nausea and vomiting;Patient satisfaction;	—

Countries

China

Contacts

Public ContactYuan Baohong

The First Affiliated Hospital of Chongqing Medical University

550188209@qq.com+86 13290009287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026